HTG Molecular Diagnostics competitors

HTG Molecular Diagnostics Competitors include Audentes Therapeutics, 23andMe, Orig3n and Co-Diagnostics.
Add company...
HTG Molecular Diagnostics
HTG Molecular Diagnostics
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.
Audentes Therapeutics
Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
23andMe
23andMe
23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.
Orig3n
Orig3n
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Co-Diagnostics
Co-Diagnostics
Co-Diagnostics is a molecular diagnostics company with a mathematical approach to DNA test design.
Founding Date
Founding Date
1997
Founding Date
2013
Founding Date
2006
Founding Date
2014
Founding Date
2013
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Tucson, US HQ
Locations
San Francisco, US HQ
Locations
Mountain View, US HQ
Locations
Boston, US HQ
Locations
Sandy, US HQ
Employees
Employees
948% increase
Employees
975% decrease
Employees
6422% increase
Employees
395% decrease
Employees
12
Valuation ($)
Valuation ($)
97.7 m
Valuation ($)
998.5 m
Valuation ($)
1.7 b
Valuation ($)
N/A
Valuation ($)
27.6 m
Twitter followers
Twitter followers
220
Twitter followers
392
Twitter followers
79.4 k
Twitter followers
14.1 k
Twitter followers
378

Financial

Revenue (est.)
Revenue (est.)
$14.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$7.7k (FY, 2017)
Cost of goods
Cost of goods
$5m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$302 (FY, 2017)
Gross profit
Gross profit
$9.8m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$7.4k (FY, 2017)
Net income
Net income
($19m) (FY, 2017)
Net income
($90.2m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($7m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 300m (5 months ago)
Latest funding round
$ 14.4m (5 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 47.2m
Total funding raised
$ 180m
Total funding raised
$ 829.5m
Total funding raised
$ 50m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Audentes Therapeutics
HQ
San Francisco, US
Employees
97↓ 5% decrease

Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.

View company
23andMe
HQ
Mountain View, US
Employees
642↑ 2% increase

23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.

View company
Orig3n
HQ
Boston, US
Employees
39↓ 5% decrease

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

View company
Co-Diagnostics
HQ
Sandy, US
Employees
12

Co-Diagnostics is a molecular diagnostics company with a mathematical approach to DNA test design.

View company